Category: Moms

L-carnitine and heart disease

L-carnitine and heart disease

Johri AM, Heyland DK, Hetu MF, L-darnitine B, Spence JD. Miyagawa T, Kawamura H, Obuchi M, et al. Paediatr Drugs Criticism is constructive.

L-carnitine and heart disease -

toolbar search Search Dropdown Menu. toolbar search search input Search input auto suggest. Abstract During cardiac failure, cardiomyocytes have difficulty in using the substrates to produce energy. You do not currently have access to this content.

View full article. Sign in Don't already have an account? Individual Login LOGIN TO MY KARGER. Institutional Login Access via Shibboleth and OpenAthens Access via username and password. Digital Version Pay-Per-View Access.

BUY THIS Article. Buy Token. This article is also available for rental through DeepDyve. View Metrics. Email alerts Online First Alert.

Latest Issue Alert. Citing articles via Web Of Science 8. CrossRef Latest Most Read Most Cited Eicosanoids and oxylipin signature in HH patients are similar to DIOS patients but are impacted by dietary iron absorption. Consumption Pattern of Tea Is Associated with Serum Ferritin Levels of Women of Childbearing Age in Nandi County, Kenya: A Cross-Sectional Study.

Suggested Reading The Prognostic Significance of Chronic Kidney Disease on the All-Cause Death of Ischemic Heart Failure in the Chinese Population: A Prospective Cohort Study Cardiorenal Med May, Suppressor of Cytokine Signaling 3 Is a Negative Regulator for Neointimal Hyperplasia of Vein Graft Stenosis J Vasc Res March, Outcome of Renal Insufficiency Patients Undergoing Coronary Artery Bypass Graft Surgery Cardiology February, Online ISSN Print ISSN Karger International S.

Karger AG P. View at Publisher View at Google Scholar Suzuki Y, Masumura Y, Kobayashi A, Yamazaki N, Harada Y, Osawa M.

Myocardial carnitine deficiency in chronic heart failure. View at Publisher View at Google Scholar Lanni N, Chiumiento P, Pannella G, Grimaldi U, D'Auria M, Imbimbo N. Impiego della carnitina nella terapia dell'insufficienza cardiaca: contributo clinico [Use of carnitine in cardiac insufficiency: clinical contribution].

Clin Ter Nov 15; 95 3 View at Publisher View at Google Scholar York CM, Cantrell CR, Borum PR. Arch Biochem Biophys Mar; 2 View at Publisher View at Google Scholar Ramos AC, Elias PR, Barrucand L, Da Silva JA.

Pediatr Res Sep; 18 9 View at Publisher View at Google Scholar Pierpont ME, Judd D, Borgwardt B, Noren GR, Staley NA, Einzig S.

Pediatr Res. May; 19 5 PMID: 6. View at Publisher View at Google Scholar Ghidini O, Azzurro M, Vita G, Sartori G. Int J Clin Pharmacol Ther Toxicol Apr; 26 4 Erratum in: Int J Clin Pharmacol Ther Toxicol Aug; 27 8 View at Publisher View at Google Scholar Gasparetto A, Corbucci GG, De Blasi RA, Antonelli M, Bagiella E, D'Iddio S, Trevisani C.

Int J Clin Pharmacol Res; 11 2 View at Publisher View at Google Scholar Kobayashi A, Masumura Y, Yamazaki N. L-carnitine treatment for congestive heart failure--experimental and clinical study.

Jpn Circ J Jan; 56 1 View at Publisher View at Google Scholar Fernandez C, Proto C. La L-carnitina nel trattamento dell'ischemia miocardica cronica. Analisi dei risultati di tre studi multicentrici e rassegna bibliografica [L-carnitine in the treatment of chronic myocardial ischemia. An analysis of 3 multicenter studies and a bibliographic review].

Clin Ter. Apr; 4 View at Publisher View at Google Scholar Bartels GL, Remme WJ, Pillay M, Schönfeld DH, Cox PH, Kruijssen HA, Knufman NM. Acute improvement of cardiac function with intravenous L-propionylcarnitine in humans.

J Cardiovasc Pharmacol Jul; 20 1 View at Publisher View at Google Scholar Mancini M, Rengo F, Lingetti M, Sorrentino GP, Nolfe G. Arzneimittelforschung Sep; 42 9 View at Publisher View at Google Scholar Pucciarelli G, Mastursi M, Latte S, Sacra C, Setaro A, Lizzadro A, Nolfe G.

Nov; 11 View at Publisher View at Google Scholar Iliceto S, Scrutinio D, Bruzzi P, D'Ambrosio G, Boni L, Di Biase M, Biasco G, Hugenholtz PG, Rizzon P. J Am Coll Cardiol x Aug; 26 2 View at Publisher View at Google Scholar Singh RB, Niaz MA, Agarwal P, Beegum R, Rastogi SS, Sachan DS.

A randomised, double-blind, placebo-controlled trial of L-carnitine in suspected acute myocardial infarction. Postgrad Med J Jan; 72 View at Publisher View at Google Scholar Kawasaki N, Lee JD, Shimizu H, Ueda T.

J Card Fail;2 4 View at Publisher View at Google Scholar Ferrari R, De Giuli F. The propiony l-L-carnitine hypothesis: an alternative approach to treating heart failure.

J Card Fail Sep;3 3 View at Publisher View at Google Scholar Näveri HK, Leinonen H, Kiilavuori K, Härkönen M. Cause of limited exercise capacity?

Eur Heart J Dec;18 12 a0 View at Publisher View at Google Scholar Anand I, Chandrashekhan Y, De Giuli F, Pasini E, Mazzoletti A, Confortini R, Ferrari R.

Cardiovasc Drugs Ther Jul;12 3 View at Publisher View at Google Scholar Rizos I. Am Heart J Feb; 2 Pt 3 :S View at Publisher View at Google Scholar Tarantini G, Scrutinio D, Bruzzi P, Boni L, Rizzon P, Iliceto S.

A randomized controlled trial. View at Publisher View at Google Scholar TD, Mohr FW, Khalimonchuk O, Weimer BC, Doenst T. Cardiovasc Res Jan 15; 85 2 View at Publisher View at Google Scholar Serati AR, Motamedi MR, Emami S, Varedi P, Movahed MR. L-carnitine treatment in patients with mild diastolic heart failure is associated with improvement in diastolic function and symptoms.

Cardiology; 3 View at Publisher View at Google Scholar Xu XQ, Jing ZC, Jiang X, Zhao QH, He J, Dai LZ, Wu WH, Li Y, Yao J.

Zhonghua Xin Xue Guan Bing Za; 38 2 PMID: [Article in Chinese]. View at Publisher View at Google Scholar Omori Y, Ohtani T, Sakata Y, Mano T, Takeda Y, Tamaki S, Tsukamoto Y, Kamimura D, Aizawa Y, Miwa T, Komuro I, Soga T, Yamamoto K.

J Hypertens View at Publisher View at Google Scholar Cheng L, Tang XF. Zhonghua Liu Xing Bing Xue Za Zhi. PMID 20 [Article in Chinese]. View at Publisher View at Google Scholar Song X, Qu H, Yang Z, Rong J, Cai W, Zhou H. Biomed Res Int; View at Publisher View at Google Scholar Moreira da Silva Guimarães S, de Souza Cruz WM, de Souza Weigert G, Scalco FB, Colafranceschi AS, Ribeiro MG, Boaventura GT.

Arch Med Res;49 4 View at Publisher View at Google Scholar Wang Y, Xu Y, Zou R, Wu L, Liu P, Yang H, Xie Z, Wang C. Paediatr Drugs View at Publisher View at Google Scholar Shahidi M, Hashemi SR, Fattahi N, Roshani D, Vahedi S, Sharifi P, Moradveisi B.

J Pediatr Hematol Oncol Aug; 42 6 View at Publisher View at Google Scholar Journal of Clinical Research and Reports I would be very delighted to submit my testimonial regarding the reviewer board and the editorial office.

The reviewer board were accurate and helpful regarding any modifications for my manuscript. And the editorial office were very helpful and supportive in contacting and monitoring with any update and offering help. It was my pleasure to contribute with your promising Journal and I am looking forward for more collaboration.

The Journal of Neuroscience and Neurological Surgery. I strongly recommend the amazing journal. They surprised us with their high efficiency in the reviewing process.

It only took a couple of days for them to gather five high-quality reviews, which was incredible. The editor office is patience and nice. The provided correct guide towards the payments process. I did not face many troubles when I was doing the international transfer.

The articles published in the journal are very practical and interesting to the clinicians. International Journal of Clinical Nephrology. We are very glad to say that the peer review process was very successful and fast.

Therefore, we would like to continue our scientific relationship again. Thank you very much for the editing of our manuscript. The peer-review process which consisted high quality queries on the paper. The support from the editorial office is excellent.

Dear Editorial coordinator, Journal of Clinical Research and Reports. Your review process was excellent, the support that I needed was perfect, the quality of the Journal appears to be very good.

We will see the number and quality of the readers soon in Research Gate. Journal of Neuroscience and Neurological Surgery. I had the experience of publishing a research article recently.

The whole process was simple from submission to publication. The reviewers made specific and valuable recommendations and corrections that improved the quality of my publication. I strongly recommend this Journal.

Archives of Medical Case Reports and Case Study, As I wrote in one of my previous mail, work together with your Reviewers is always stimulating and gives me every time this is the second new sparks to improve my article.

The researchers chose those which were comparative trials of adults over 18 receiving L-Carnitine compared with a placebo or control with outcomes of all-cause mortality, cardiovascular events including myocardial reinfarction , and development of heart failure and ventricular arrhythmias, which are abnormal heart rhythms.

The literature review yielded studies, but only 18 were reviewed in full and 13 were deemed eligible for inclusion. DiNicolantonio, Carl J.

Lavie, Hassan Fares, Arthur R. Menezes, and James H. Content provided by LEHVOSS Nutrition Sep Data Sheet. Commitment to sustainability at Golden Omega® is ever growing as they continue to put objectives in place to secure a better environment for the future Content provided by Cabio Biotech Wuhan Co.

Omega-3 long-chain polyunsaturated fatty acids PUFAs have numerous positive health benefits and are among the most extensively studied micronutrients Content provided by ADM May Infographic.

Carnitine is a substance that diseaae the body turn hewrt into energy. L-carnitjne body makes it in the liver L-carnitine and heart disease Non-GMO produce Body composition tracking stores it in the skeletal neart, heart, brain, and sperm. Usually, L-carntiine body can make all the dissease it needs. Some people, however, may not have enough carnitine because their bodies cannot make enough or cannot transport it into tissues so it can be used. Other conditions, such as angina or intermittent claudication, can also cause low levels of carnitine in the body, as can some medications. Carnitine has been proposed as a treatment for many conditions because it acts as an antioxidant. Antioxidants fight harmful particles in the body known as free radicals, which damage cells and tamper with DNA. L-carnitine and heart disease

Author: Kagagar

2 thoughts on “L-carnitine and heart disease

  1. Ich meine, dass Sie den Fehler zulassen. Ich biete es an, zu besprechen. Schreiben Sie mir in PM, wir werden umgehen.

Leave a comment

Yours email will be published. Important fields a marked *

Design by